111 related articles for article (PubMed ID: 23719950)
1. Analysis of circulating microRNA by microarray in liver disease.
Murakami Y; Tanahashi T
Methods Mol Biol; 2013; 1024():173-82. PubMed ID: 23719950
[TBL] [Abstract][Full Text] [Related]
2. A combination of extraction reagent and DNA microarray that allows for the detection of global miRNA profiles from serum/plasma.
Ichikawa M; Akiyama H
Methods Mol Biol; 2013; 1024():247-53. PubMed ID: 23719957
[TBL] [Abstract][Full Text] [Related]
3. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients.
Dai Y; Huang YS; Tang M; Lv TY; Hu CX; Tan YH; Xu ZM; Yin YB
Lupus; 2007; 16(12):939-46. PubMed ID: 18042587
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis.
Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D
Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610
[TBL] [Abstract][Full Text] [Related]
6. Microarray analysis of miRNA gene expression.
Thomson JM; Parker JS; Hammond SM
Methods Enzymol; 2007; 427():107-22. PubMed ID: 17720481
[TBL] [Abstract][Full Text] [Related]
7. Methods for microRNA microarray profiling.
Ranade AR; Weiss GJ
Methods Mol Biol; 2011; 700():145-52. PubMed ID: 21204032
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages.
Sukata T; Sumida K; Kushida M; Ogata K; Miyata K; Yabushita S; Uwagawa S
Toxicol Lett; 2011 Jan; 200(1-2):46-52. PubMed ID: 21035526
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
[TBL] [Abstract][Full Text] [Related]
10. Extracellular microRNA: a new source of biomarkers.
Etheridge A; Lee I; Hood L; Galas D; Wang K
Mutat Res; 2011 Dec; 717(1-2):85-90. PubMed ID: 21402084
[TBL] [Abstract][Full Text] [Related]
11. Detection of microRNAs in prostate cancer cells by microRNA array.
Tang X; Tang X; Gal J; Kyprianou N; Zhu H; Tang G
Methods Mol Biol; 2011; 732():69-88. PubMed ID: 21431706
[TBL] [Abstract][Full Text] [Related]
12. Extracellular miRNAs: the mystery of their origin and function.
Turchinovich A; Weiz L; Burwinkel B
Trends Biochem Sci; 2012 Nov; 37(11):460-5. PubMed ID: 22944280
[TBL] [Abstract][Full Text] [Related]
13. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
Weiland M; Gao XH; Zhou L; Mi QS
RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic microRNAs in stage II colon cancer.
Schepeler T; Reinert JT; Ostenfeld MS; Christensen LL; Silahtaroglu AN; Dyrskjøt L; Wiuf C; Sørensen FJ; Kruhøffer M; Laurberg S; Kauppinen S; Ørntoft TF; Andersen CL
Cancer Res; 2008 Aug; 68(15):6416-24. PubMed ID: 18676867
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNAs in the cerebrospinal fluid of patients with brain diseases.
Machida A; Ohkubo T; Yokota T
Methods Mol Biol; 2013; 1024():203-9. PubMed ID: 23719953
[TBL] [Abstract][Full Text] [Related]
16. Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis.
Qin B; Huang F; Liang Y; Yang Z; Zhong R
J Gastroenterol Hepatol; 2013 Mar; 28(3):543-50. PubMed ID: 23173724
[TBL] [Abstract][Full Text] [Related]
17. Nanopore single-molecule detection of circulating microRNAs.
Gu LQ; Wang Y
Methods Mol Biol; 2013; 1024():255-68. PubMed ID: 23719958
[TBL] [Abstract][Full Text] [Related]
18. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.
Kuwabara Y; Ono K; Horie T; Nishi H; Nagao K; Kinoshita M; Watanabe S; Baba O; Kojima Y; Shizuta S; Imai M; Tamura T; Kita T; Kimura T
Circ Cardiovasc Genet; 2011 Aug; 4(4):446-54. PubMed ID: 21642241
[TBL] [Abstract][Full Text] [Related]
19. The role and clinical implications of microRNAs in hepatocellular carcinoma.
Zhao X; Yang Z; Li G; Li D; Zhao Y; Wu Y; Robson SC; He L; Xu Y; Miao R; Zhao H
Sci China Life Sci; 2012 Oct; 55(10):906-19. PubMed ID: 23108868
[TBL] [Abstract][Full Text] [Related]
20. Assessing sample and miRNA profile quality in serum and plasma or other biofluids.
Blondal T; Jensby Nielsen S; Baker A; Andreasen D; Mouritzen P; Wrang Teilum M; Dahlsveen IK
Methods; 2013 Jan; 59(1):S1-6. PubMed ID: 23036329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]